Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

about

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

Item

http://www.wikidata.org/entity/Q42156384

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@en

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@nl

type

Item

label

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@en

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@nl

prefLabel

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@en

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@nl

P1476

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

@en

P2093

Abhay Gundgurthi

http://www.w3.org/2001/XMLSchema#string

Aditi Pandit

http://www.w3.org/2001/XMLSchema#string

Karninder S Brar

http://www.w3.org/2001/XMLSchema#string

M K Garg

http://www.w3.org/2001/XMLSchema#string

Sandeep Kharb

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

Hyperthyroid vs hypothyroid eye disease: the same severity and activity.

Quality of life in patients with benign thyroid disorders. A review.

B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.

B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.

Clinical practice. Graves' ophthalmopathy.

P304

344-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4103/2230-8210.109669

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239942630

http://www.w3.org/2001/XMLSchema#string

P698

23776919

http://www.w3.org/2001/XMLSchema#string

P932

3683221

http://www.w3.org/2001/XMLSchema#string